ASX - By Stock
|
BOT |
Re:
Post-FDA decision price sweep
|
|
jackphil
|
124 |
35K |
5 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
124
|
35K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
jackphil
|
8.9K |
3.3M |
8 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
8.9K
|
3.3M
|
8
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
jackphil
|
8.9K |
3.3M |
4 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
8.9K
|
3.3M
|
4
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
jackphil
|
8.9K |
3.3M |
16 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
8.9K
|
3.3M
|
16
|
|
ASX - By Stock
|
BOT |
Re:
28 Cent Club
|
|
jackphil
|
230 |
94K |
1 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
230
|
94K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Investor Presentation
|
|
jackphil
|
45 |
16K |
9 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
45
|
16K
|
9
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Investor Presentation
|
|
jackphil
|
45 |
16K |
11 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
45
|
16K
|
11
|
|
ASX - By Stock
|
OCC |
Re:
Movement at the Station
|
|
jackphil
|
71 |
22K |
4 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
71
|
22K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
What's the chances? Future sell out to big pharma, or go our own way?
|
|
jackphil
|
7 |
4.1K |
7 |
13/10/22 |
13/10/22 |
ASX - By Stock
|
7
|
4.1K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
jackphil
|
45 |
18K |
3 |
12/10/22 |
12/10/22 |
ASX - By Stock
|
45
|
18K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
jackphil
|
1.7K |
498K |
0 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
1.7K
|
498K
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Striate Global License and Distribution Agreement Update
|
|
jackphil
|
69 |
23K |
0 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
69
|
23K
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Striate Global License and Distribution Agreement Update
|
|
jackphil
|
69 |
23K |
2 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
69
|
23K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
EDISON OPEN HOUSE 2022
|
|
jackphil
|
4 |
1.8K |
9 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
4
|
1.8K
|
9
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OrthoATI Tendon Clinical Study Success
|
|
jackphil
|
241 |
63K |
11 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
241
|
63K
|
11
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
jackphil
|
13K |
4.7M |
0 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
13K
|
4.7M
|
0
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
jackphil
|
1.7K |
498K |
1 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
1.7K
|
498K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Ortho-ATI Shoulder Tendon Study Database Lock
|
|
jackphil
|
161 |
39K |
2 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
161
|
39K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Ortho-ATI Shoulder Tendon Study Database Lock
|
|
jackphil
|
161 |
39K |
2 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
161
|
39K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Ortho-ATI Shoulder Tendon Study Database Lock
|
|
jackphil
|
161 |
39K |
5 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
161
|
39K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
jackphil
|
1.7K |
498K |
2 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
1.7K
|
498K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
jackphil
|
13K |
4.7M |
0 |
14/10/21 |
14/10/21 |
ASX - By Stock
|
13K
|
4.7M
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Appendix 4E and Annual Report to Shareholders
|
|
jackphil
|
59 |
12K |
10 |
30/08/21 |
30/08/21 |
ASX - By Stock
|
59
|
12K
|
10
|
|
ASX - By Stock
|
OCC |
Re:
Ann: CelGro Facilitates Lymphatic Vessel Regeneration
|
|
jackphil
|
41 |
11K |
7 |
04/08/21 |
04/08/21 |
ASX - By Stock
|
41
|
11K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
jackphil
|
13K |
4.7M |
6 |
25/06/21 |
25/06/21 |
ASX - By Stock
|
13K
|
4.7M
|
6
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
jackphil
|
8.9K |
3.3M |
2 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
jackphil
|
8.9K |
3.3M |
9 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
9
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
jackphil
|
8.9K |
3.3M |
27 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
27
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
jackphil
|
8.9K |
3.3M |
5 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
jackphil
|
8.9K |
3.3M |
2 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
jackphil
|
8.9K |
3.3M |
12 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
12
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
jackphil
|
1K |
291K |
6 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
1K
|
291K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Botanix Pharmaceuticals further explaining their Excellent results
|
|
jackphil
|
9 |
4.2K |
11 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
9
|
4.2K
|
11
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
jackphil
|
1K |
291K |
5 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
1K
|
291K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
jackphil
|
1K |
291K |
2 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
1K
|
291K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Botanix Pharmaceuticals further explaining their Excellent results
|
|
jackphil
|
9 |
4.2K |
12 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
9
|
4.2K
|
12
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
jackphil
|
1K |
291K |
4 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
1K
|
291K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
jackphil
|
1K |
291K |
2 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
1K
|
291K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
jackphil
|
1K |
291K |
2 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
1K
|
291K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
jackphil
|
1K |
291K |
1 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
1K
|
291K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
jackphil
|
1K |
291K |
3 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
1K
|
291K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
jackphil
|
1K |
291K |
2 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
1K
|
291K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
jackphil
|
1K |
291K |
4 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
1K
|
291K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
jackphil
|
1K |
291K |
3 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
1K
|
291K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
jackphil
|
1K |
291K |
1 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
1K
|
291K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
jackphil
|
1K |
291K |
1 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
1K
|
291K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Dream big with BOT. What is next for BOT after phase 2 ?
|
|
jackphil
|
92 |
29K |
0 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
92
|
29K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
jackphil
|
1K |
291K |
0 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
1K
|
291K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
jackphil
|
1K |
291K |
1 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
1K
|
291K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
jackphil
|
1K |
291K |
1 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
1K
|
291K
|
1
|
|